Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease
The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Huntington's disease (HD) is characterized by a triad of motor, psychiatric and cognitive symptoms. Although many of these symptoms are likely to be related to central nervous system pathology, others may be due to changes in peripheral tissues. The R6/2 mouse, a transgenic model of HD expressing exon 1 of the human HD gene, develops progressive alterations in the hypothalamic-pituitary-adrenal axis, reminiscent of a Cushing-like syndrome. We observed muscular atrophy, reduced bone mineral density, abdominal fat accumulation and insulin resistance in the mice. All these changes could be consequences of increased glucocorticoid levels. Indeed, hypertrophy of the adrenal cortex and a progressive increase in serum and urine corticosterone levels were found in R6/2 mice. In addition, the intermediate pituitary lobe was markedly enlarged and circulating adreno-corticotrophic hormone (ACTH) increased. Under normal conditions dopamine represses the ACTH expression. In the R6/2 mice, however, the expression of pituitary dopamine D2 receptors was reduced by half, possibly explaining the increase in ACTH. Urinary samples from 82 HD patients and 68 control subjects were analysed for cortisol: in accord with the observations in the R6/2 mice, urinary cortisol increased in parallel with disease progression. This progressive increase in cortisol may contribute to the clinical symptoms, such as muscular wasting, mood changes and some of the cognitive deficits that occur in HD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ultimately, excessive ACTH leads to activation and hypertrophy of the adrenal cortex in aged HD mice, resulting in elevated cortisol levels,367 that may contribute to impaired glucose metabolism,368 skeletal muscle atrophy, and weight loss.369”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [367]
Citations
Cites
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Self-citationDavies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., Ross, C. A., Scherzinger, E., Wanker, E. E., Mangiarini, L., & Bates, G. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80513-9 · Cited by 2,181
Self-citationGlucocorticoids and Hippocampal Atrophy in Neuropsychiatric Disorders
Sapolsky, R. M. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.10.925 · Cited by 2,016
Physiology and pharmacology of corticotropin-releasing factor.
Owens, M. J., & Nemeroff, C. B. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06673-6 · Cited by 1,142
Adult neurogenesis is regulated by adrenal steroids in the dentate gyrus
Cameron, H. A., & Gould, E. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90224-0 · Cited by 998
Carter, R. J., Lione, L. A., Humby, T., Mangiarini, L., Mahal, A., Bates, G. P., Dunnett, S. B., & Morton, A. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-08-03248.1999 · Cited by 947
Self-citationHockly, E., Richon, V. M., Woodman, B., Smith, D. L., Zhou, X., Rosa, E., Sathasivam, K., Ghazi-Noori, S., Mahal, A., Lowden, P. A. S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437870100 · Cited by 845
Self-citationHuntington disease: Clinical care and evaluation
Shoulson, I., & Fahn, S. (1979) · Neurology · doi:10.1212/wnl.29.1.1 · Cited by 746
Sp1 and TAFII130 Transcriptional Activity Disrupted in Early Huntington's Disease
Dunah, A. W., Jeong, H., Griffin, A., Kim, Y.-M., Standaert, D. G., Hersch, S. M., Mouradian, M. M., Young, A. B., Tanese, N., & Krainc, D. (2002) · Science · doi:10.1126/science.1072613 · Cited by 708
Cha, J.-H. J., Kosinski, C. M., Kerner, J. A., Alsdorf, S. A., Mangiarini, L., Davies, S. W., Penney, J. B., Bates, G. P., & Young, A. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6480 · Cited by 504
Self-citation
Cited by
Items 101–152 of 152
McCourt, A. C., Parker, J., Silajdžić, E., Salman, H., Sethi, H., Tabrizi, S. J., Warner, T. T., & Björkqvist, M. (2015) · Journal of Huntington s Disease · doi:10.3233/jhd-150172 · Cited by 16
Self-citationLate onset vascular dysfunction in the R6/1 model of Huntington’s disease
Rahman, A., Ekman, M., Shakirova, Y., Andersson, K. E., Mörgelin, M., Erjefalt, J. S., Brundin, P., Li, J., & Swärd, K. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.10.026 · Cited by 15
Self-citationKlonarakis, M., Vos, M. D., Woo, E. K., Ralph, L. T., Thacker, J. S., & Gil‐Mohapel, J. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104541 · Cited by 15
Gil‐Mohapel, J., & Rego, A. C. (2001) · Revista Neurociências · doi:10.34024/rnc.2011.v19.8332 · Cited by 15
Hypothalamic pathology in Huntington disease
van Wamelen, D. J., & Aziz, N. A. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819973-2.00017-4 · Cited by 12
Sexually dimorphic dopaminergic dysfunction in a transgenic mouse model of Huntington's disease
Renoir, T., Argyropoulos, A., Chevarin, C., Lanfumey, L., & Hannan, A. J. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.10.004 · Cited by 11
Mo, C., Renoir, T., & Hannan, A. J. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.044 · Cited by 10
Biomarkers for brain disorders
Ward, M. A., & Schofield, E. (2010) · Therapy · doi:10.2217/thy.10.31 · Cited by 10
Altered cerebrovascular response to acute exercise in patients with Huntington’s disease
Steventon, J. J., Furby, H., Ralph, J., O’Callaghan, P., Rosser, A., Wise, R. G., Busse, M. E., & Murphy, K. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa044 · Cited by 10
Biomarkers for Huntington's disease
Wild, E. J., & Tabrizi, S. J. (2008) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2.1.47 · Cited by 10
Self-citationGastrointestinal disorders in hyperkinetic movement disorders and ataxia
Pradeep, S., & Mehanna, R. (2021) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2021.09.005 · Cited by 9
Gentenaar, M., Meulmeester, F. L., van der Burg, X. R., Hoekstra, A. T., Hunt, H., Kroon, J., van Roon‐Mom, W., & Meijer, O. C. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114675 · Cited by 9
Kane, A. D., Niu, Y., Herrera, E. A., Morton, A. J., & Giussani, D. A. (2016) · Scientific Reports · doi:10.1038/srep25979 · Cited by 9
Effects of excitotoxicity in the hypothalamus in transgenic mouse models of Huntington disease
Henningsen, J. B., Soylu-Kucharz, R., Björkqvist, M., & Petersén, Å. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e07808 · Cited by 9
Self-citationCircadian Interventions in Preclinical Models of Huntington’s Disease: A Narrative Review
Dell’Angelica, D., Singh, K., Colwell, C. S., & Ghiani, C. A. (2024) · Biomedicines · doi:10.3390/biomedicines12081777 · Cited by 8
Analysis of Nonmotor Features in Murine Models of Huntington Disease
Baldo, B., & Petersén, Å. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405195-9.00035-4 · Cited by 8
Self-citationBrain–Periphery Interactions in Huntington’s Disease: Mediators and Lifestyle Interventions
Burtscher, J., Strasser, B., Pepe, G., Burtscher, M., Kopp, M., Pardo, A. D., Maglione, V., & Khamoui, A. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094696 · Cited by 8
The Urine Metabolome of R6/2 and zQ175DN Huntington’s Disease Mouse Models
Speziale, R., Montesano, C., Pietro, G. D., Cicero, D. O., Summa, V., Monteagudo, E. S., & Orsatti, L. (2023) · Metabolites · doi:10.3390/metabo13080961 · Cited by 6
Stress and Glucocorticoids as Experience-Dependent Modulators of Huntington's Disease
Mo, C., Renoir, T., & Hannan, A. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813146-6.00020-5 · Cited by 5
Polyglutamine disease in peripheral tissues
Barwell, T., & Seroude, L. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddad138 · Cited by 4
Hyrskyluoto, A. (2014) · Helda - University of Helsinki Institutional Repository · Cited by 3
Deregulated Transcriptome as a Platform for Adrenal Huntington’s Disease-Related Pathology
Olechnowicz, A., Blatkiewicz, M., Jopek, K., Isalan, M., Mielcarek, M., & Ruciński, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042176 · Cited by 2
Biomarkers for Huntington’s Disease
Kobal, J., Lovrei, L., & Peterli, B. (2012) · InTech eBooks · doi:10.5772/32757 · Cited by 2
Petersén, Å. (2010) · European Neurological Review · doi:10.17925/enr.2010.05.02.49 · Cited by 1
Self-citationSingh, A., & Agrawal, N. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01078-2 · Cited by 1
Preclinical Experimental Therapeutics
Bates, G. P., & Landles, C. (2014) · Oxford University Press eBooks · doi:10.1093/med/9780199929146.003.0016 · Cited by 1
Self-citationNeuroprotection Mediated by Prolactin during Excitotoxicity: New Functions and Insights
Molina-Salinas, G., Rodríguez-Chávez, V., & Cerbón, M. A. (2024) · Pharmaceutical science. · doi:10.5772/intechopen.113798 · Cited by 1
Feyeux, M. (2011) · theses.fr (ABES) · doi:10.70675/d3786477zc560z42e3za489z601932156212 · Cited by 1
Ionic mechanisms of circadian disruption
Kuljis, D. A. (2015) · eScholarship (California Digital Library)
Huntington’s disease : hypothalamic, endocrine and metabolic aspects
Aziz, N. A. (2010) · Leiden Repository (Leiden University)
β-cell dysfunction in Huntington's disease
Bacos, K. (2009) · Lund University Publications (Lund University)
Self-citationBurg, M., & Jorien, M. (2008) · Lund University Publications (Lund University)
Study of novel pathogenic mechanisms in Huntington disease
Alberti, S. (2013)
Schneider, N. (2014) · OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) · doi:10.18725/oparu-3505
Ricerca, D. I. D., & Orobello, S. (2010)
A study of depression in Huntington's disease
Pang, T. Y. (2008) · Minerva Access (University of Melbourne)
Mechanisms of neurodegeneration in transgenic models of Huntington's disease
Gil, J. M. D. A. C. (2007) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Self-citationApolinário, T. A., Maciel, T. D. M. A. M., & Paiva, C. L. A. (2016) · REVISTA CIENTÍFICA DA FAMINAS
Bartlett, D. M. (2018) · Research Online (Edith Cowan University)
Energy metabolism as a target for new treatment strategies in Huntington’s disease
Sjögren, M. (2019) · Lund University Publications (Lund University)
Dickson, E., Fryklund, C., Soylu-Kucharz, R., Sjögren, M., Stenkula, K. G., & Björkqvist, M. (2023) · Journal of Huntington s Disease · doi:10.3233/jhd-230587
Self-citationRôles normal et pathologique des phosphorylations de la huntingtine par Cdk5
M’Barek, K. B. (2012) · theses.fr (ABES) · doi:10.70675/53a5c6a1zd813z445bza73bza84d5d3008fa
The clinical utility of multidisciplinary rehabilitation in individuals with Huntington’s Disease
Cruickshank, T. M. (2015) · Research Online (Edith Cowan University)
Rytmy okołodobowe melatoniny i kortyzolu w wybranych chorobach neurologicznych
(2014) · Wielkopolska Digital Library
Olechnowicz, A., Blatkiewicz, M., Isalan, M., Koc, A., Mielcarek, M., & Ruciński, M. (2025) · Medical Journal of Cell Biology · doi:10.2478/acb-2025-0005
Orvoën, S. (2012) · theses.fr (ABES) · doi:10.70675/fc4072b8z23c7z4c2bzb5adz05babcfc2144
Troubles hormonaux et leur implication dans la progression de la maladie de Huntington
Saleh, N. (2009) · theses.fr (ABES) · doi:10.70675/082f2f5fzb60fz4183za5d2z91bba74ee6d7
Maladie de Huntington : huntingtine, connectivité neuronale et métabolisme oxydatif
Capellano, L. (2025) · theses.fr (ABES) · doi:10.70675/dd0b8f65z490fz446fz8d1azd0dd5619a044
Khan, Z. A. (2012) · Research Online (Edith Cowan University)
Metadata
- Authors
- Björkqvist, M., Petersén, Å., Bacos, K., Isaacs, J., Norlén, P., Gil, J., Popovic, N., Sundler, F., Bates, G. P., Tabrizi, S. J., Brundin, P., & Mulder, H.
- Affiliations
- Lund University (SE)
- Corresponding author
- Björkqvist, Maria
- ORCID
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-04-13
- Volume
- 15
- Issue
- 10
- Pages
- 1713-1721
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2164413723
- Cited by
- 138
- References
- 48
- Citations by year
- 2025: 3 · 2024: 7 · 2023: 4 · 2022: 5 · 2021: 6 · 2020: 3 · 2019: 8 · 2018: 2 · 2017: 2 · 2016: 6 · 2015: 8 · 2014: 12 · 2013: 10 · 2012: 8
- FWCI
- 3.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- Huntington's disease, R6/2 transgenic mice, hypothalamic-pituitary-adrenal axis, corticosterone, ACTH, dopamine D2 receptor, adrenal cortex hypertrophy, insulin resistance, bone mineral density, muscle atrophy, urinary cortisol, disease progression
- MeSH terms
- Huntingtin Protein, Adrenocorticotropic Hormone, Adult, Animals, Corticosterone, Disease Models, Animal, Dopamine, Female, Humans, Huntington Disease, Hydrocortisone, Hypothalamo-Hypophyseal System, Insulin Resistance, Male, Mice, Transgenic, Middle Aged, Muscular Atrophy, Nerve Tissue Proteins, Nuclear Proteins, Pituitary-Adrenal System, Bone Density, Receptors, Dopamine D2, Body Fat Distribution, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.